FDA, United Therapeutics
Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), recently executed a series of stock transactions, according to a recent SEC filing. On February 3, Benkowitz sold shares ...
The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...
The research offers hope to tens of thousands of patients with kidney failure who are on a long waiting list for an organ ...
The U.S. Food and Drug Administration has approved the first-ever clinical trials testing pig kidney transplants in people ...
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results